C-Tb

BIOLOGICAL5 trials

Sponsors

Statens Serum Institut

Conditions

Tuberculosis

Phase 2

A Trial of the C-Tb Skin Test, When Given Intradermally to Adult Patients Recently Diagnosed With Active Tuberculosis (TB)

CompletedNCT01241188

Statens Serum InstitutTuberculosis

Start: 2011-04-30End: 2011-12-31Updated: 2015-04-17

A Trial of the C-Tb Skin Test, When Given Intradermally to Healthy Volunteers Previously Vaccinated With BCG

CompletedNCT01242475

Statens Serum InstitutTuberculosis

Start: 2011-04-30End: 2011-11-30Updated: 2013-01-21

Safety Study Investigating if Concomitant Injections of C-Tb and 2 T.U Tuberculin Affect Induration Responses

CompletedNCT01779102

Statens Serum InstitutTuberculosis

Start: 2013-10-31End: 2014-09-30Updated: 2015-04-17

Phase 3

Comparison of Diagnostic Performance of C-Tb to QuantiFERON®-TB, in Combination With a Safety Assessment of C-Tb vs Tuberculin PPD RT23 SSI

CompletedNCT01631266

Statens Serum InstitutTuberculosis

Start: 2012-07-31End: 2014-10-31Updated: 2015-04-17

A Trial in Subjects Suspected to Have Tuberculosis, Comparing the Diagnostic Performance of C-Tb to QuantiFERON®, in Combination With a Safety Assessment of C-Tb Versus Tuberculin PPD RT23 SSI

CompletedNCT01642888

Statens Serum InstitutTuberculosis

Start: 2012-09-30End: 2014-09-30Updated: 2016-04-14

Related Papers

C-Tb skin test to diagnose Mycobacterium tuberculosis infection in children and HIV-infected adults: A phase 3 trial

PLoS ONE2018-09-2462 citations

Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon γ release assay and the tuberculin skin test: a phase 3, double-blind, randomised, controlled trial.

2017-02-0169 citations

Randomised clinical trial investigating the specificity of a novel skin test (C-Tb) for diagnosis of M. tuberculosis infection.

2013-05-1440 citations